Mali 1976.

Study characteristics
Methods	Trial design: randomised, double‐blind, parallel study Trial registration number, country: not reported Outpatient or hospital: private clinic Date trial conducted: not reported Duration of trial participation: 3 weeks Inclusion criteria: people with steroid‐responsive dermatosis, with eczema data presented separately Exclusion criteria: not reported Additional design details: none
Participants	Total number randomised: 66 (total cohort included AD, psoriasis, other dermatoses ‐ unclear how many in the total randomised for AD) participants Age, sex, ethnicity, duration of eczema, severity of eczema, body site: not reported Number of withdrawals: 16 because of concomitant systemic corticosteroid therapy, broken code, or insufficient data. (unclear how many of these were AD participants) Notes: none
Interventions	Run‐in details: not reported Intervention: betamethasone dipropionate cream used twice daily for 21 days · Concurrent treatment: not reported · Other key information: brand: diprosone Comparator: flumethasone pivalate 0.2% cream used twice daily for 21 days · Concurrent treatment: not reported · Other key information: none Concurrent treatments received alongside both intervention and comparator: not reported Notes: none
Outcomes	Patients and physicians combined overall evaluation (extracted into clinical reported signs binary)
Notes	Funding source: not reported Declarations of interest: not declared Original language of publication: English Other: none